PEN vs TVTX
Penumbra, Inc. vs Travere Therapeutics, Inc. — AI-powered side-by-side comparison
PEN
Penumbra, Inc.
67
Buy
VS
TVTX
Travere Therapeutics, Inc.
62
Buy
| Metric | PEN | TVTX |
|---|
| AI Score |
67
|
62
|
| Price |
$326.07
|
$60.25
|
| P/E Ratio |
79.78×
|
-133.80×
|
| ROE |
12.4%
|
-22.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
67.8%
|
94.4%
|
| Debt / Equity |
0.14×
|
25.16×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
79.6
|
59.0
|
| Beta |
0.701
|
1.042
|
| Expected Upside |
+6.3%
|
—
|
AI Committee View
Current Innellis committee reasoning for PEN versus TVTX.
PEN leads by 5 points.
PEN scores 67/100 (Buy) versus TVTX at 62/100 (Buy).
PEN Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is 2 consecutive earnings misses -- execution concerns. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- 2 consecutive earnings misses -- execution concerns — Growth
- RSI at 80 is in overbought territory — Technical
TVTX Committee View
75% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 17.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- Bollinger bandwidth of 17.2% signals elevated volatility — Risk